IL‐34 is a potential biomarker for the treatment of papillary thyroid cancer

BACKGROUND: Interleukin (IL)‐34 is a recently discovered pro‐inflammatory cytokine and is a vital regulator in different tumor types. However, the function of IL‐34 in thyroid carcinoma has yet to be investigated. In this study, we analyzed the expression of IL‐34 in human papillary thyroid cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ping, Zhang, Hao, Dong, Wenwu, Wang, Zhihong, Qin, Yuan, Wu, Changhao, Dong, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439428/
https://www.ncbi.nlm.nih.gov/pubmed/32573824
http://dx.doi.org/10.1002/jcla.23335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439428/
https://www.ncbi.nlm.nih.gov/pubmed/32573824
http://dx.doi.org/10.1002/jcla.23335

Ejemplares similares